Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Isofol’s Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19

GOTHENBURG, Sweden, February 14, 2024 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), has been engaged in intensive strategy work since the new Board of Directors and management took office in January. The Board of Directors has decided today to prepare a new development program for arfolitixorin, with the goal of initiating new clinical studies as soon as possible. The company intends to present details of the strategic direction on March 19, along with holding an investor meeting.The information in the press release below is intended for investors.  During the past year and

Golden Boomerang Awards 2024: Annual Global Traffic Tournament

The Golden Boomerang Awards  is the first tournament organized by Boomerang Partners to reward affiliates who drive high-quality traffic to its online gambling platforms. Running from February 14th to May 14th, 2024 this exclusive tournament offers affiliates a prime opportunity to showcase their traffic generation skills, with the potential to secure booming rewards, including cash prizes, VIP benefits, stylish merchandise, and real gold trophies.The tournament welcomes both existing and

Form 8.3 - Mondi Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Neste renews Green Finance Framework

Neste Corporation, News, 14 February 2024Neste has published a renewed Green Finance Framework to align future financing activities with market best practices and standards.Neste published its first Green Finance Framework in 2021 and since then has issued four green bonds totalling EUR 2.1 billion and entered into one green term loan of EUR 500 million. The proceeds from green finance have been allocated to renewable and circular solution projects including Neste’s Singapore refinery expansion, Rotterdam refinery expansion and Martinez Renewables joint operation. Further information is

First day to exercise Catena Media’s warrants (CTM TO1) for subscription of new shares during 16th exercise period

Catena Media plc today announces that the 16th period to subscribe for shares in the company by exercise of warrants (ticker CTM TO1) (“the warrants”) commences today, 14 February 2024, and will run until and including 23 February 2024. During this period, each warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 18.90. Payment of subscribed shares can be made in cash or through set-off with the full nominal amount of each hybrid capital security (ticker CATME HO1) that the warrant holder uses for set-off. The nominal amount of one (

Wärtsilä Corporation’s Annual Report 2023 published

Wärtsilä Corporation, Stock exchange release, 14 February 2024 at 13:00 EETWärtsilä Corporation’s Annual Report 2023 published Wärtsilä Corporation has today, 14 February 2024, published its Annual Report for the year 2023. The Annual Report contains a Business review, the Corporate Governance Statement, the Remuneration Report 2023, a Sustainability review, the Board of Director’s Report, and the Financial Statements 2023. The Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The format is Extensible Hypertext

Unleashing the Green Revolution: Ekobot's Journey to becoming a market leader

Company: EkobotListings: First North StockholmTicker: EkobotMarket cap at time of publication: 11 million SEKStock price at time of publication: 0,58 SEKComparable peers: Farmdroid, Naio TechnologiesBusiness:  Sustainable agriculture technologyWebsite: https://www.ekobot.se/ Executive summary:We are initiating coverage on the Swedish agtech company Ekobot. Ekobot is a company redefining the traditional global agricultural landscape through cutting-edge technology. Ekobot addresses the pressing need for sustainable land management. The company has developed an innovative

Hamlet BioPharma Enters Commercial Collaborations with Top International Advisory Firms to Enhance Partnering and Strategic Alliances

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce that it has entered into commercial collaborations with two premier international advisory firms. Under the new collaborations, the advisory firms will offer expert support to Hamlet BioPharma, leveraging their global networks and deep industry knowledge to identify and negotiate potential partnerships for commercial opportunities and strategic alliances. “The collaborations are expected to accelerate Hamlet BioPharma’s strategic partnering initiatives

Teneo 7.4 Launches with Groundbreaking Generative AI Copilot Features to Transform Chat Development

Teneo.ai , a brand from Artificial Solutions, is thrilled to announce the release of Teneo Studio 7.4, a groundbreaking update that introduces a suite of advanced Generative AI capabilities designed to revolutionize the development of chat and conversational interfaces. With the integration of the innovative Copilot features, developers can now effortlessly integrate their LLM into their bot, taking chat interfaces to the next level.Add Your Own LLM Model: A Unified Development Experience  Teneo Studio 7.4 redefines the customizability of the development process by

BioStock: Elicera gets green light for CAR T clinical study

Elicera Therapeutics has gotten the approval to begin a phase I/IIa study with lead CAR T candidate ELC-301 in B cell lymphoma, mantle cell lymphoma or indolent lymphoma. This is a key milesone for the Swedish biotech, who is banking on its iTANK technology platform to enhance a patient’s immune system in the face of cancer. BioStock spoke with Elicera’s CEO Jamal El-Mosleh to learn more.Read the interview with Jamal El-Mosleh at biostock.se: Elicera gets green light for CAR T clinical study - BioStock 

BioStock: Strong start for Annexin in 2024

Annexin Pharmaceuticals had a successful 2023, and the new year seems to be starting with continued success. Positive signals of effect have now been observed in the majority of patients treated in the phase II study in retinal vein occlusion. Additionally, the company emerged strengthened from an oversubscribed rights issue that added SEK 35.6 million at the turn of the year. BioStock reached out to CEO Anders Haegerstrand for a comment.Read the article about Annexin Pharmaceuticals here: https://www.biostock.se/en/2024/02/strong-start-for-annexin-in-2024/ This is a press release

Metsä Group to invest in three new converting lines to Mariestad’s tissue paper mill in Sweden

Metsä Group’s tissue and greaseproof paper business is investing in three new state-of-the-art converting lines for folded and rolled tissue paper to its mill in Mariestad, Sweden. The investment will enable large scale high quality hand towel production in Scandinavia. In addition it entails efficiency and energy savings as well as improved working environment and safety. The investments are part of the company´s expansion and modernisation investment in Mariestad and strategic Future Mill programme, aimed at world-class environmental and operational performance.Metsä is investing SEK 4.2

Notice to Annual General Meeting in Atrium Ljungberg AB (publ)

The shareholders of Atrium Ljungberg AB (publ) are hereby invited to the Annual General Meeting to be held on 21 March 2024 at 5.00 p.m. at Filmstaden, Marcusplatsen 19 in Sickla, NackaThe Board of Directors has decided that shareholders shall have the right to exercise their voting rights in advance through an absentee ballot pursuant to Chapter 7, section 4 a of the Swedish Companies Act (2005:551) and the Company’s Articles of Association. Consequently, shareholders may choose to exercise their voting rights at the General Meeting by attending by absentee ballot, in person or through a

Norwegian Minister of Climate and Environment visited Elkem in Thamshavn

Elkem’s climate strategy and contribution to building competitive, green industry and jobs were among the topics discussed during the visit to Elkem in Thamshavn by the Norwegian Minister of Climate and Environment, Andreas Bjelland Eriksen February 13.Elkem is a leading producer of materials which are crucial in driving the green transition. Silicon from Elkem is used in electric cars, batteries and other renewable energy technologies, making it a key component in the green transition.Elkem's Thamshavn plant produces silicon with only one-third of the global average of CO2 emissions for

Compliance with Market Abuse Regulations

14 February 2024   Fidelity European Trust PLC (“the Company”)   LEI: 549300UC0QPP7Y0W8056   Compliance with Market Abuse Regulations   The Company wishes to notify the market that the closed period of the Company in relation to its annual results for the period ended 31 December 2023 will commence on 14 February 2024 (today) and is anticipated to end no sooner than 14 March 2024.   The Company confirms that all inside information (as defined in the EU Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory

NOBA Holding AB (publ)’s subsidiary NOBA Bank Group AB (publ) has called for early redemption of its NOBA30 and NOBA31 notes

NOBA Holding AB (publ)’s indirect subsidiary NOBA Bank Group AB (publ) (“NOBA”) has today notified Nordic Trustee AS, as the VPS trustee, of the exercise of its call options for each of the senior preferred floating rate notes of NOK 700,000,000 (NOBA30, ISIN NO0010952823) and SEK 300,000,000 (NOBA31, ISIN NO0010952831) (together the “Notes”) on the first call date, 18 March 2024, in accordance with the terms and conditions for the Notes. The Notes were issued under the EUR 1,500,000,000 Euro Medium Term Note Programme of Bank Norwegian ASA (the debt capital instruments of which were

Early redemption and call option notice for NOBA Bank Group AB (publ)’s NOBA30 and NOBA31 notes

NOBA Bank Group AB (publ) (“NOBA” or the “Company”) has today notified Nordic Trustee AS, as the VPS trustee, of the exercise of its call options for each of the senior preferred floating rate notes of NOK 700,000,000 (NOBA30, ISIN NO0010952823) and SEK 300,000,000 (NOBA31, ISIN NO0010952831) (together the “Notes”) on the first call date, 18 March 2024, in accordance with the terms and conditions for the Notes. The Notes were issued under the EUR 1,500,000,000 Euro Medium Term Note Programme of Bank Norwegian ASA (the debt capital instruments of which were assumed by NOBA in the merger

Securitas invites to an Investor Day in Stockholm on March 7, 2024

Securitas welcomes representatives from the financial market and media to an Investor Day in Stockholm on March 7, 2024, starting at 14.00 to around 17.00 CET.The Investor Day will provide a review of the company’s strategy and extensive transformation over the past few years, the sustainability focus and the financial development, and financial targets. The event will take place at Securitas’ headquarters at Lindhagensplan 70 in Stockholm.The Investor Day is also webcasted live and will be recorded to be made available at securitas.com after the event. Agenda 14.00: · Magnus

Nordic Kitchen & Bar opens at Arlanda

Nordic Kitchen & Bar is now opening at Stockholm Arlanda Airport. With a menu and a design that puts the Nordic and Scandinavian in focus, and with star chef Michael Spiridon at the helm, the restaurant hopes to take travellers by storm. Restaurant Nordic Kitchen & Bar has a view out of the ordinary. Through the high glass sections that go from floor to ceiling, there is a front row seat to be able to see all the aircraft taking off and landing. The interior of the restaurant and bar has a clear Nordic material palette with a light colour scheme and the menu is also characterised by

Gaming Innovation Group - Mandatory notification of trade

Hesam Yazdi, board member and primary insider of Gaming Innovation Group Inc. (GiG), has today purchased 4,000 shares in GiG at a price of SEK 29.50 per share. After this transaction, Hesam Yazdi and close associates owns 950,500 shares in GiG, including 66,600 shares via pension savings plans. For further information, contact: Tore Formo, Group CFO, tore@gig.com +47 91668678 This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.  About Gaming Innovation Group (GiG)Gaming Innovation Group is a leading

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 34 - 14 FEBRUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Aker Solutions to support the industrial transformation of Mongstad

February 14, 2024 - Aker Solutions has been awarded a contract by Equinor to carry out a feasibility study for its Mongstad Industrial Transformation project in Vestland county on the west coast of Norway. Credit: Espen Rønnevik/©Equinor. The study aims to identify solutions to significantly reduce CO2 emissions from the existing refinery and transform the site into a new low-carbon industry cluster whilst demonstrating safe, technical, and economically feasible solutions. The scope includes a new greenfield facility which will be developed to produce blue hydrogen from natural

NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy

Today Wednesday on February 14th at 10.30 CET Dr. Mathias Svahn, CEO of NextCell Pharma AB (“NextCell" or the"Company"), will present the latest developments in the company at Redeye.The presentation is live broadcasted and can be followed at Redeye Theme: Regenerative Medicine/Cell Therapy - Redeye  www.redeye.se/events/966283/redeye-theme-cell-therapy where the replay and the presentations will be available afterwards.

There are no items matching the current filter
There are no more items matching the current filter
Back to top